Chennai-based medical device firm Kriya Medical Technologies on Thursday said it has received Indian Council of Medical Research approval for Krivida Novus COVID-19 testing kit—developed in collaboration with ImmuGenix Bioscience—that can also detect the Omicron variant.
The kit detects the SARS-CoV-2 virus and also differentiates the Omicron variant from Delta and other variants. The test takes about 45 minutes to detect the infection and determine the variant, the company said in a statement.
"KRIVIDA Novus is a one of its kind test that not only differentiates the variants but also detects the sub-lineages of Omicron. The kit is compatible with Real-Time PCR machines with a test run time of roughly 45 minutes," Kriya Medical Technologies CEO and Founder Anu Moturi said.